DK0780390T3 - Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne - Google Patents

Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne

Info

Publication number
DK0780390T3
DK0780390T3 DK96119134T DK96119134T DK0780390T3 DK 0780390 T3 DK0780390 T3 DK 0780390T3 DK 96119134 T DK96119134 T DK 96119134T DK 96119134 T DK96119134 T DK 96119134T DK 0780390 T3 DK0780390 T3 DK 0780390T3
Authority
DK
Denmark
Prior art keywords
cdch
preparation
pharmaceutical compositions
compositions containing
crystal modification
Prior art date
Application number
DK96119134T
Other languages
Danish (da)
English (en)
Inventor
Patrick Dr Bosche
Alfons Dr Grunenberg
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7779831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0780390(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0780390T3 publication Critical patent/DK0780390T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96119134T 1995-12-12 1996-11-29 Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne DK0780390T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19546249A DE19546249A1 (de) 1995-12-12 1995-12-12 Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
DK0780390T3 true DK0780390T3 (da) 2002-11-11

Family

ID=7779831

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96119134T DK0780390T3 (da) 1995-12-12 1996-11-29 Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne

Country Status (42)

Country Link
US (1) US5849752A (fr)
EP (1) EP0780390B1 (fr)
JP (1) JP4104687B2 (fr)
KR (1) KR100525146B1 (fr)
CN (1) CN1061348C (fr)
AR (1) AR005009A1 (fr)
AT (1) ATE221531T1 (fr)
AU (1) AU708006B2 (fr)
BG (1) BG62258B1 (fr)
BR (1) BR9605968A (fr)
CA (1) CA2192418C (fr)
CO (1) CO4480105A1 (fr)
CU (1) CU22774A3 (fr)
CZ (1) CZ288657B6 (fr)
DE (2) DE19546249A1 (fr)
DK (1) DK0780390T3 (fr)
EE (1) EE03474B1 (fr)
ES (1) ES2179910T3 (fr)
HR (1) HRP960558B1 (fr)
HU (1) HU226521B1 (fr)
ID (1) ID22625A (fr)
IL (1) IL119795A (fr)
IN (1) IN185805B (fr)
MA (1) MA24342A1 (fr)
MY (1) MY117492A (fr)
NL (1) NL300109I1 (fr)
NO (1) NO306725B1 (fr)
NZ (1) NZ299905A (fr)
PL (1) PL184885B1 (fr)
PT (1) PT780390E (fr)
RO (1) RO119782B1 (fr)
RU (1) RU2162468C2 (fr)
SA (1) SA96170492B1 (fr)
SG (1) SG47201A1 (fr)
SI (1) SI0780390T1 (fr)
SK (1) SK282805B6 (fr)
SV (1) SV1996000109A (fr)
TR (1) TR199600970A2 (fr)
TW (1) TW411340B (fr)
UA (1) UA35638C2 (fr)
YU (1) YU49485B (fr)
ZA (1) ZA9610405B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1017392T1 (en) * 1997-09-25 2002-12-31 Bayer Aktiengesellschaft Medicament formulation with a controlled release of an active agent
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
SI1128831T1 (en) * 1998-11-10 2005-04-30 Bayer Healthcare Ag Pharmaceutical moxifloxacin preparation
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
US20060252789A1 (en) * 2002-10-31 2006-11-09 Sujay Biswas Amorphous moxifloxacin hydrochloride
CA2521398C (fr) * 2003-04-09 2011-03-22 Dr. Reddy's Laboratories Limited Forme cristalline iii de chlorhydrate de moxifloxacine anhydre et procede de preparation de cette derniere
EP1651630A1 (fr) * 2003-08-05 2006-05-03 Matrix Laboratories Ltd Procede ameliore permettant de preparer un hydrochlorure de moxifloxacine
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
EP1685130B1 (fr) * 2003-11-20 2008-12-10 CHEMI S.p.A. Polymorphes d'hydrochlorure d'acide 1-cyclopropyl-7-([s,s]-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylique, et leurs methodes de preparation
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
US20100204470A1 (en) 2006-06-27 2010-08-12 Sandoz Ag method for salt preparation
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
AU2007320997B2 (en) * 2006-11-13 2012-11-08 Cipla Limited Process for the synthesis of moxifloxacin hydrochloride
EP1992626A1 (fr) * 2007-05-10 2008-11-19 Sandoz AG Procédé de préparation de chlorure de moxifloxacine
EP2083010A1 (fr) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Formes polymorphes d'hydrochlorure de moxifloxacine et leurs procédés de préparation
EP2154137A1 (fr) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Formule cristalline à base de moxifloxacine
JP5461565B2 (ja) * 2008-10-09 2014-04-02 アブディ イブラヒム イラク サナイ ベ ティカレット アノニム シルケティ 有機溶媒を使用したモキシフロキサシンの湿式造粒法
WO2010052726A1 (fr) * 2008-11-06 2010-05-14 Hetero Research Foundation Polymorphe inédit de l'hydrochlorure de moxifloxacine
WO2010066385A1 (fr) 2008-12-08 2010-06-17 Ratiopharm Gmbh Moxifloxacine compactée
WO2010131054A1 (fr) 2009-05-15 2010-11-18 Bradford Pharma Limited Dérivés redox de médicaments
WO2011121596A2 (fr) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Modification cristalline de chlorhydrate de moxifloxacine
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
WO2014087292A1 (fr) 2012-12-04 2014-06-12 Mankind Research Centre Procédé perfectionné pour la préparation de chlorhydrate de moxifloxacine
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
MX2015011760A (es) 2013-03-15 2016-06-10 Melinta Therapeutics Inc Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
NO871333L (no) * 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboksylsyrederivater, fremgangsmaate til fremstilling og anvendelse derav.
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
TW209865B (fr) 1992-01-10 1993-07-21 Bayer Ag
ATE207479T1 (de) * 1992-01-31 2001-11-15 Chugai Pharmaceutical Co Ltd Kristalle von derivaten von chinozon carbonsäure- hydraten
DE4234078A1 (de) 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
NO301165B1 (no) * 1992-12-25 1997-09-22 Daiichi Seiyaku Co Bicykliske aminderivater og antibakterielle midler inneholdende disse
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
DK0676199T3 (da) * 1994-04-07 1999-02-08 Pfizer Anvendelse af trovafloxacin eller derivater deraf til fremstilling af et medikament til behandling af H. pylori-infektione

Also Published As

Publication number Publication date
CZ364696A3 (en) 1997-07-16
ATE221531T1 (de) 2002-08-15
UA35638C2 (uk) 2001-04-16
YU49485B (sh) 2006-08-17
RO119782B1 (ro) 2005-03-30
HUP9603428A2 (en) 1997-08-28
PL184885B1 (pl) 2003-01-31
CN1160052A (zh) 1997-09-24
SK282805B6 (sk) 2002-12-03
SV1996000109A (es) 1997-10-23
ID22625A (id) 1999-12-02
NO306725B1 (no) 1999-12-13
EP0780390A1 (fr) 1997-06-25
EP0780390B1 (fr) 2002-07-31
SK159196A3 (en) 1997-10-08
EE9600201A (et) 1997-06-16
ZA9610405B (en) 1997-06-23
SG47201A1 (en) 1998-03-20
SA96170492B1 (ar) 2006-05-23
IL119795A (en) 1998-12-27
IL119795A0 (en) 1997-03-18
YU65096A (sh) 1998-12-23
HRP960558B1 (en) 2002-04-30
MY117492A (en) 2004-07-31
CA2192418A1 (fr) 1997-06-13
SI0780390T1 (en) 2002-10-31
IN185805B (fr) 2001-05-05
BR9605968A (pt) 1998-08-18
TW411340B (en) 2000-11-11
AR005009A1 (es) 1999-04-07
AU7421696A (en) 1997-06-19
CU22774A3 (es) 2002-07-24
KR970042550A (ko) 1997-07-24
NO965298L (no) 1997-06-13
BG101043A (en) 1998-04-30
NL300109I1 (nl) 2003-02-03
CA2192418C (fr) 2001-06-12
BG62258B1 (bg) 1999-06-30
MA24342A1 (fr) 1998-07-01
JP4104687B2 (ja) 2008-06-18
KR100525146B1 (ko) 2006-01-27
HU226521B1 (en) 2009-03-30
NO965298D0 (no) 1996-12-11
AU708006B2 (en) 1999-07-29
HUP9603428A3 (en) 1997-10-28
NZ299905A (en) 1998-09-24
PL317415A1 (en) 1997-06-23
US5849752A (en) 1998-12-15
RU2162468C2 (ru) 2001-01-27
PT780390E (pt) 2002-11-29
EE03474B1 (et) 2001-08-15
DE59609501D1 (de) 2002-09-05
CO4480105A1 (es) 1997-07-09
HRP960558A2 (en) 1998-02-28
MX9606325A (es) 1997-10-31
CZ288657B6 (cs) 2001-08-15
JPH09169757A (ja) 1997-06-30
HU9603428D0 (en) 1997-01-28
TR199600970A2 (tr) 1997-06-21
CN1061348C (zh) 2001-01-31
DE19546249A1 (de) 1997-06-19
ES2179910T3 (es) 2003-02-01

Similar Documents

Publication Publication Date Title
DK0780390T3 (da) Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne
DK1156049T3 (da) Substituerede heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK0861089T3 (da) Metoder og sammensætninger til indgivelse af monomere proteiner
DK0622408T3 (da) Sammensætning og fremgangsmåde til fremstilling af gelatinfrie, bløde kapsler
DK0807086T3 (da) Fremgangsmåde til fremstilling af hydrotalciter
DK0817780T3 (da) Taxoider, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser
NO964700D0 (no) Nye aminosyrederivater, fremgangsmåte til deres fremstilling og farmasöytiske blandinger som inneholder disse forbindelser
DK0496386T3 (da) Katalysatorbærer samt sammensætning og fremgangsmåde til fremstilling af denne
DK1275387T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
DK0812195T3 (da) Farmaceutisk sammensætning til piperidinoalkanolforbindelser
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
NO20000227L (no) Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmåte for dens fremstilling og dens anvendelse
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK0670367T3 (da) Flydendegørende alkalisk alfa-amylase, fremgangsmåde til fremstilling af denne og detergentsammensætning indeholdende denne
DK0773984T3 (da) Enzymholdig granuleret substans og fremgangsmåde til fremstilling heraf
DK0845943T3 (da) Nye peptider afledt fra humant heat shock protein 60 til behandling af diabetes, sammensætninger, fremgangsmåder og kits
DK0839138T3 (da) Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0805797T3 (da) Fremgangsmåde til fremstilling af N-aryl- og N-hetarylhydroxylaminer
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK0719775T3 (da) Substituerede derivater af 4-phenylthiazol, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, der inde
DK102990A (da) Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
DK0821680T3 (da) Nye taxoider, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler